Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lauro Wichert-Ana is active.

Publication


Featured researches published by Lauro Wichert-Ana.


Neuropsychopharmacology | 2004

Effects of Cannabidiol (CBD) on Regional Cerebral Blood Flow

José Alexandre S. Crippa; Antonio Waldo Zuardi; Griselda J. Garrido; Lauro Wichert-Ana; Ricardo Guarnieri; Lucas Ferrari; Paulo M. Azevedo-Marques; Jaime Eduardo Cecílio Hallak; Philip McGuire; Geraldo F. Busatto

Animal and human studies have suggested that cannabidiol (CBD) may possess anxiolytic properties, but how these effects are mediated centrally is unknown. The aim of the present study was to investigate this using functional neuroimaging. Regional cerebral blood flow (rCBF) was measured at rest using 99mTc-ECD SPECT in 10 healthy male volunteers, randomly divided into two groups of five subjects. Each subject was studied on two occasions, 1 week apart. In the first session, subjects were given an oral dose of CBD (400 mg) or placebo, in a double-blind procedure. SPECT images were acquired 90 min after drug ingestion. The Visual Analogue Mood Scale was applied to assess subjective states. In the second session, the same procedure was performed using the drug that had not been administered in the previous session. Within-subject between-condition rCBF comparisons were performed using statistical parametric mapping (SPM). CBD significantly decreased subjective anxiety and increased mental sedation, while placebo did not induce significant changes. Assessment of brain regions where anxiolytic effects of CBD were predicted a priori revealed two voxel clusters of significantly decreased ECD uptake in the CBD relative to the placebo condition (p<0.001, uncorrected for multiple comparisons). These included a medial temporal cluster encompassing the left amygdala–hippocampal complex, extending into the hypothalamus, and a second cluster in the left posterior cingulate gyrus. There was also a cluster of greater activity with CBD than placebo in the left parahippocampal gyrus (p<0.001). These results suggest that CBD has anxiolytic properties, and that these effects are mediated by an action on limbic and paralimbic brain areas.


Journal of Psychopharmacology | 2011

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report

José Alexandre S. Crippa; Guilherme Nogueira Derenusson; Thiago Borduqui Ferrari; Lauro Wichert-Ana; Fábio L.S. Duran; R. Martin-Santos; Marcus Vinicius Simões; Sagnik Bhattacharyya; Paolo Fusar-Poli; Zerrin Atakan; Alaor Santos Filho; Maria Cecília Freitas-Ferrari; Philip McGuire; Antonio Waldo Zuardi; Geraldo F. Busatto; Jaime Eduardo Cecílio Hallak

Animal and human studies indicate that cannabidiol (CBD), a major constituent of cannabis, has anxiolytic properties. However, no study to date has investigated the effects of this compound on human pathological anxiety and its underlying brain mechanisms. The aim of the present study was to investigate this in patients with generalized social anxiety disorder (SAD) using functional neuroimaging. Regional cerebral blood flow (rCBF) at rest was measured twice using (99m)Tc-ECD SPECT in 10 treatment-naïve patients with SAD. In the first session, subjects were given an oral dose of CBD (400 mg) or placebo, in a double-blind procedure. In the second session, the same procedure was performed using the drug that had not been administered in the previous session. Within-subject between-condition rCBF comparisons were performed using statistical parametric mapping. Relative to placebo, CBD was associated with significantly decreased subjective anxiety (p < 0.001), reduced ECD uptake in the left parahippocampal gyrus, hippocampus, and inferior temporal gyrus (p < 0.001, uncorrected), and increased ECD uptake in the right posterior cingulate gyrus (p < 0.001, uncorrected). These results suggest that CBD reduces anxiety in SAD and that this is related to its effects on activity in limbic and paralimbic brain areas.


Revista Brasileira de Psiquiatria | 2015

Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report

Flávia de Lima Osório; Rafael Faria Sanches; Lígia Ribeiro Horta Macedo; Rafael G. dos Santos; Joao Paulo Maia-de-Oliveira; Lauro Wichert-Ana; Draulio B. de Araujo; Jordi Riba; José Alexandre S. Crippa; Jaime Eduardo Cecílio Hallak

OBJECTIVES Ayahuasca (AYA), a natural psychedelic brew prepared from Amazonian plants and rich in dimethyltryptamine (DMT) and harmine, causes effects of subjective well-being and may therefore have antidepressant actions. This study sought to evaluate the effects of a single dose of AYA in six volunteers with a current depressive episode. METHODS Open-label trial conducted in an inpatient psychiatric unit. RESULTS Statistically significant reductions of up to 82% in depressive scores were observed between baseline and 1, 7, and 21 days after AYA administration, as measured on the Hamilton Rating Scale for Depression (HAM-D), the Montgomery-Åsberg Depression Rating Scale (MADRS), and the Anxious-Depression subscale of the Brief Psychiatric Rating Scale (BPRS). AYA administration resulted in nonsignificant changes in Young Mania Rating Scale (YMRS) scores and in the thinking disorder subscale of the BPRS, suggesting that AYA does not induce episodes of mania and/or hypomania in patients with mood disorders and that modifications in thought content, which could indicate psychedelic effects, are not essential for mood improvement. CONCLUSIONS These results suggest that AYA has fast-acting anxiolytic and antidepressant effects in patients with a depressive disorder.


Seizure-european Journal of Epilepsy | 2006

Seizure outcome after surgery for epilepsy due to focal cortical dysplastic lesions

Veriano Alexandre; Roger Walz; Marino Muxfeldt Bianchin; Tonicarlo Rodrigues Velasco; Vera C. Terra-Bustamante; Lauro Wichert-Ana; David Araújo; Hélio Rubens Machado; João Alberto Assirati; Carlos Gilberto Carlotti; Antonio C. Santos; Luciano Neder Serafini; Américo C. Sakamoto

Neocortical development is a highly complex process encompassing cellular proliferation, neuronal migration and cortical organization. At any time this process can be interrupted or modified by genetic or acquired factors causing malformations of cortical development (MCD). Epileptic seizures are the most common type of clinical manifestation, besides developmental delay and focal neurological deficits. Seizures due to MCD are frequently pharmacoresistant, especially those associated to focal cortical dysplasia (FCD). Surgical therapy results have been reported since 1971, however, currently available data from surgical series are still limited, mainly due to small number of patients, distinct selection of candidates and surgical strategies, variable pathological diagnosis and inadequate follow-up. This study addresses the possibilities of seizure relief following resection of focal cortical dysplasia, and the impact of presurgical evaluation, extent of resection and pathological findings on surgical outcome. We included 41 patients, 22 adults and 19 children and adolescents, with medically intractable seizures operated on from 1996 to 2002. All were submitted to standardized presurgical evaluation including high-resolution MRI, Video-EEG monitoring and ictal SPECT. Post-surgical seizure outcome was classified according to Engels schema. Univariate and multivariate analysis were performed. Fifteen patients had temporal and 26 extratemporal epilepsies. Of the total 26 patients (63.4%) reached seizure-free status post-operatively. There was no correlation between outcome and age at surgery, duration of epilepsy, frequency of seizures, and pathological findings. There was, however, a clear correlation with topography of FCD (temporal versus extratemporal) and regional ictal EEG onset, on univariate as well as multivariate analysis.


Epilepsia | 2006

Volumetric Evidence of Bilateral Damage in Unilateral Mesial Temporal Lobe Epilepsy

David Araújo; Antonio C. Santos; Tonicarlo Rodrigues Velasco; Lauro Wichert-Ana; Vera C. Terra-Bustamante; Veriano Alexandre; Carlos Gilberto Carlotti; João Alberto Assirati; Hélio Rubens Machado; Roger Walz; João Pereira Leite; Américo Ceiki Sakamoto

Summary:  Purpose: We sought to analyze the contralateral volumes of the temporal pole, posterior segment of the temporal lobe, amygdala, hippocampus, and parahippocampal gyrus in patients with temporal lobe epilepsy (TLE) due to histologically proven mesial temporal lobe sclerosis (MTLS), seizure free for ≥4 years of postsurgical follow‐up.


Epilepsia | 2005

Clinical features of patients with posterior cortex epilepsies and predictors of surgical outcome

Charles L. Dalmagro; Marino Muxfeldt Bianchin; Tonicarlo Rodrigues Velasco; Veriano Alexandre; Roger Walz; Vera C. Terra-Bustamante; Luciana M. Inuzuka; Lauro Wichert-Ana; David Araújo; Luciano Neder Serafini; Carlos Gilberto Carlotti; João Alberto Assirati; Hélio Rubens Machado; Antonio C. Santos; Américo Ceiki Sakamoto

Summary:  Purpose: Posterior cortex epilepsies (PCEs) encompass a group of epilepsies originating from the occipital, parietal, or occipital border of the temporal lobe, or from any combination of these regions. When their seizures are refractory to pharmacologic treatment, these patients are usually referred for surgery. The aim of our study was to analyze clinical characteristics of all PCE patients referred for surgery from 1994 to 2003, and to search for predictors of surgical outcome.


Behavioural Brain Research | 2005

Altered behavioural response to acute stress in mice lacking cellular prion protein

Patrícia Barreto Costa Nico; Fernanda de-Paris; Elsa Regina do Canto Vinade; Olavo B. Amaral; Isabel Cristina Rockenbach; Bruno Lobão Soares; Ricardo Guarnieri; Lauro Wichert-Ana; Fabrício Calvo; Roger Walz; Ivan Izquierdo; Américo C. Sakamoto; Ricardo R. Brentani; Vilma R. Martins; Marino Muxfeldt Bianchin

Although many studies have investigated the function of cellular prion protein (PrPc), its physiologic role remains elusive. PrPc null mice have been reported to develop normally and to show normal performance in most behavioural tests. In the present study we investigated whether this also holds true after episodes of acute stress. PrPc gene ablated (Prnp0/0) and wild-type mice were subjected to restraint stress, electric foot shock, or swimming and compared with non-stressed animals. Immediately after the stressful situation, the anxiety levels and locomotion of the animals were measured using plus-maze and open-field tests. Among non-stressed animals, there was no significant difference in performance between Prnp0/0 and wild type animals in either test. However, after acute stress provoked by a foot shock or a swimming trial, Prnp0/0 animals showed a significant decrease in anxiety levels when compared with control animals. Moreover, after the swimming test, knockout mice presented decreased locomotion when compared to wild-type mice. Because of this observation, we also assessed both types of mice in a forced swimming test with the objective of better evaluating muscle function and found that Prnp0/0 animals presented reduced forced swimming capacity when compared to controls. As far as we know, this is the first report suggesting that cellular prion protein is involved in modulation of anxiety or muscular activity after acute psychic or physical stress.


Neurology | 2003

Surgical outcome in mesial temporal sclerosis correlates with prion protein gene variant.

Roger Walz; Rosa Maria R.P.S. Castro; Tonicarlo Rodrigues Velasco; Veriano Alexandre; Marilene H. Lopes; João Pereira Leite; Antonio Carlos dos Santos; João Alberto Assirati; Lauro Wichert-Ana; Vera C. Terra-Bustamante; Marino Muxfeldt Bianchin; P. C. Maciag; Karina Braga Ribeiro; Ricardo Guarnieri; David Araújo; O. Cabalero; Ricardo Moura; A. C M Salim; K. Kindlmann; Michele Christine Landemberger; Wilson Marques; Regina Maria França Fernandes; Luciano Neder Serafini; Hélio Rubens Machado; Carlos Gilberto Carlotti; Ricardo R. Brentani; Américo C. Sakamoto; Vilma R. Martins

Background: Mesial temporal lobe epilepsy related to hippocampal sclerosis (MTLE-HS) is the most common surgically remediable epileptic syndrome. Ablation of the cellular prion protein (PrPc) gene (PRNP) enhances neuronal excitability of the hippocampus in vitro and sensitivity to seizure in vivo, indicating that PrPc might be related to epilepsy. Objective: To evaluate the genetic contribution of PRNP to MTLE-HS. Methods: The PRNP coding sequence of DNA from peripheral blood cells of 100 consecutive patients with surgically treated MTLE-HS was compared to that from a group of healthy controls adjusted for sex, age, and ethnicity (n = 180). The presence of PRNP variant alleles was correlated with clinical and presurgical parameters as well as surgical outcome. Results: A variant allele at position 171 (Asn→Ser), absent in controls, was found in heterozygosis (Asn171Ser) in 23% of patients (p < 0.0001). The PRNP genotypes were not correlated with any clinical or presurgical data investigated. However, patients carrying the Asn171Ser variant had a five times higher chance of continuing to have seizures after temporal lobectomy (95% CI 1.65 to 17.33, p = 0.005) than those carrying the normal allele. At 18 months after surgery, 91.8% of patients with the normal allele at codon 171 were seizure free, in comparison to 68.2% of those carrying Asn171Ser (p = 0.005). Conclusions: The PRNP variant allele Asn171Ser is highly prevalent in patients with medically untreatable MTLE-HS and influences their surgical outcome. The results suggest that the PRNP variant allele at codon 171 (Asn171Ser) is associated with epileptogenesis in MTLE-HS.


Seizure-european Journal of Epilepsy | 2005

Temporal lobe epilepsy surgery in children and adolescents: clinical characteristics and post-surgical outcome.

Vera C. Terra-Bustamante; Luciana M. Inuzuca; Regina Maria França Fernandes; Sandra Souza Funayama; Sara Escorsi-Rosset; Lauro Wichert-Ana; Antonio C. Santos; David Araújo; Hélio Rubens Machado; Américo Ceiki Sakamoto

BACKGROUND AND PURPOSE Temporal lobe epilepsy (TLE) encompasses 10-20% of the cases of intractable epilepsy in pediatric patients. Mesial temporal sclerosis (MTS) can still be encountered in adolescent patients, but is rare in children under 5 years of age. In this paper we report on the surgical outcome of a series of TLE patients ranging in age from 1 to 18 years at the time of operation. PATIENTS AND METHODS Thirty-five patients (37 surgeries) with medically intractable TLE were operated upon between January 1996 and December 2002. The following variables were analyzed: age at surgery, age at epilepsy onset, history of an initial precipitating injury, etiology, seizure semiology, interictal and ictal EEG findings, surgical complications, and post-surgical seizure outcome. RESULTS There were 68.6% females and 31.3% males, and complex partial seizures (CPS) occurred in 86.5%. The most common etiology was MTS (40%) followed by isolated cortical developmental abnormalities (22.9%). In the age group up to 5 years, cortical development abnormalities predominated, and 71% of these children had multifocal interictal EEG. Patients older than 10 years had more frequently MTS (78.6%) and focal temporal interictal EEG abnormalities. Post-surgical seizure outcome showed that 88.5% of patients were in Engel classes I and II. CONCLUSIONS Adolescents with TLE had clinical features, electrographic findings, and seizure outcome similar to those observed in adult patients. However, younger children up to 5 years of age had distinct ictal semiology and different etiological, electrophysiological and outcome profiles, clearly suggesting that they behave as a special subgroup within the TLE.


Childs Nervous System | 2005

Surgically amenable epilepsies in children and adolescents: clinical, imaging, electrophysiological, and post-surgical outcome data

Vera C. Terra-Bustamante; Regina Maria França Fernandes; Luciana M. Inuzuka; Tonicarlo Rodrigues Velasco; Veriano Alexandre; Lauro Wichert-Ana; Sandra Souza Funayama; Eliana Garzon; Antonio C. Santos; David Araújo; Roger Walz; João Alberto Assirati; Hélio Rubens Machado; Américo C. Sakamoto

Background and purposeA large number of patients with epilepsy in the pediatric population have medically intractable epilepsy. In this age group seizures are usually daily or weekly, and response to antiepileptic therapy is poor, especially for those with neurological abnormalities and symptomatic epilepsies. However, several authors have already demonstrated similarly favorable long-term post-surgical seizure control when comparing pediatric and adult populations. In this article we aim to report the experience of the Ribeirão Preto Epilepsy Surgery Program in pediatric epilepsy surgery.Patients and methodsWe analyzed 107 patients with medically intractable epilepsy operated on between July 1994 and December 2002, considering age at surgery, seizure type, pathological findings, and seizure outcome. All data were prospectively collected according to protocols previously approved by the institution ethics committee.ResultsWe analyzed a total of 115 operations performed in 107 patients. There was no difference in sex distribution. Complex partial seizures occurred in 31.4% of the patients, followed by tonic seizures (25.9%), focal motor seizures (15.4%), and infantile spasms (13.3%). The most common etiologies were cortical developmental abnormalities (25.2%), tumors (16.8%), mesial temporal sclerosis (15.9%), Rasmussen syndrome (6.5%), and tuberous sclerosis (6.5%). Overall post-surgical seizure outcome showed 67.2% of the patients within Engel classes I and II, reaching 75.0% when patients with callosotomies were excluded.ConclusionsPost-surgical seizure control in the pediatric population is similar to that in adult patients, despite the fact that epilepsies in this age group are more frequently of extratemporal origin, suggesting that surgery should be considered in children as soon as intractability is determined.

Collaboration


Dive into the Lauro Wichert-Ana's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David Araújo

University of São Paulo

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mery Kato

University of São Paulo

View shared research outputs
Researchain Logo
Decentralizing Knowledge